You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

recurrent cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Head Neck Cancer, Recurrent Cancer Trial in Guangzhou (Penicillamine)

Not yet recruiting
  • Head and Neck Cancer
  • Recurrent Cancer
  • Guangzhou, Guangdong, China
    Southern medical university
Oct 24, 2023

Exploration of Locally Recurrent Colorectal Cancer

Recruiting
  • Locally Recurrent Colorectal Cancer
  • salvage surgery
  • Beijing, Beijing, China
    Cancer Hospital, Chinese Academy of Medical Sciences & Peking Un
Oct 28, 2023

Cadonilimab in Recurrent or Metastatic Cervical Cancer

Not yet recruiting
  • Recurrent or Metastatic Cervical Cancer
  • (no location specified)
Nov 23, 2023

Ovarian Cancer Recurrent Trial (Fluzopril Combined With Apatinib)

Not yet recruiting
  • Ovarian Cancer Recurrent
  • Fluzopril Combined With Apatinib
  • (no location specified)
Oct 22, 2023

Recurrent Prostate Cancer Patients

Not yet recruiting
  • Recurrent Prostate Cancer
    • San Francisco, California
      Power Life Sciences
    Sep 30, 2023

    Participation Patterns Among Recurrent Ovarian Cancer Patients

    Not yet recruiting
    • Recurrent Ovarian Cancer
      • San Francisco, California
        Power Life Sciences
      Sep 30, 2023

      PET on Surgery for Loco-regionally Recurrent Colorectal Cancer

      Completed
      • PET-driven Surgery
      • Loco-regional Recurrent Colorectal Cancer
      • Curative intent surgery
      • Taipei, Taiwan
        National Taiwan University Hospital
      Jul 2, 2023

      Prostate Cancer Trial in Hamilton, London, Toronto (18F-DCFPyL PET/CT scan)

      Completed
      • Prostate Cancer
      • 18F-DCFPyL PET/CT scan
      • Hamilton, Ontario, Canada
      • +3 more
      Mar 24, 2022

      Endometrial Cancer, Endometrioid Tumor, Cancer Trial in Oklahoma City (nab-sirolimus)

      Not yet recruiting
      • Endometrial Cancer
      • +5 more
      • Oklahoma City, Oklahoma
        University Oklahoma Stephenson Cancer Center
      Aug 16, 2023

      The International Centre for Recurrent Head and Neck Cancer

      Not yet recruiting
      • Head Cancer Neck
        • (no location specified)
        May 30, 2023

        Recurrent Cancer, Primary Cancer, Second Cancer Trial in Lyon (Dostarlimab)

        Not yet recruiting
        • Recurrent Cancer
        • +2 more
        • Lyon, France
          Centre Léon Bérard
        May 12, 2023

        Recurrent Ovarian Cancer Trial in Pittsburgh (CPI-0209, carboplatin)

        Not yet recruiting
        • Recurrent Ovarian Cancer
        • Pittsburgh, Pennsylvania
          Magee-Womens Research Institute / UPMC Magee Womens Hospital
        Jul 3, 2023

        Cervical Cancer Trial (Nimotuzumab?Tislelizumab)

        Not yet recruiting
        • Cervical Cancer
        • (no location specified)
        Sep 9, 2023

        Cervical Cancer Recurrent Trial in Beijing (RC48 + Tislelizumab)

        Recruiting
        • Cervical Cancer Recurrent
        • RC48 + Tislelizumab
        • Beijing, Beijing, China
          Peking Union Medical College Hospital
        Sep 25, 2023

        Recurrent Vulvar Cancer, Persistent Vulvar Cancer, Metastatic Vulva Cancer Trial (Pembrolizumab, Lenvatinib)

        Not yet recruiting
        • Recurrent Vulvar Cancer
        • +3 more
        • (no location specified)
        Jun 12, 2023

        AK104 Combined With I-125 Brachytherapy for Recurrent or

        Not yet recruiting
        • Cervical Cancer
        • Iodine-125 particle brachytherapy
        • AK104
        • (no location specified)
        Sep 25, 2023

        Prostate Cancer, Recurrent Prostate Cancer, PET Positive Trial run by the National Cancer Institute (NCI) (Enzalutamide, M9241)

        Not yet recruiting
        • Prostate Cancer
        • +2 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Oct 27, 2023

        Pathologically Confirmed Cancer Refractory to Conventional Therapy, Refractory Cancer, Metastatic Cancer Trial in Santa Monica

        Not yet recruiting
        • Pathologically Confirmed Cancer Refractory to Conventional Therapy
        • +7 more
        • SNK02
        • Santa Monica, California
          Sarcoma Oncology Center
        Aug 10, 2023

        A Prospective, Randomized Controlled Study of Cyclophosphamide,

        Not yet recruiting
        • Epithelial Ovarian Cancer
        • Shijiazhuang, Hebei, China
          Hebei
        Aug 20, 2023

        Rectal Cancer, Recurrent Trial in Shanghai (Carbon ion radiation therapy DT: 74Gy/20 fractions)

        Not yet recruiting
        • Rectal Cancer
        • Recurrent
        • Carbon ion radiation therapy DT: 74Gy/20 fractions
        • Shanghai, Pudong, China
          Shanghai Proton and Heavy ion center
        Apr 7, 2023

        Recurrent Ovarian Cancer Trial (DOXIL, Withaferin A, Ashwagandha)

        Not yet recruiting
        • Recurrent Ovarian Cancer
        • (no location specified)
        Jan 27, 2023

        Endometrial Cancer, Endometrial Adenocarcinoma Trial (Cadonilimab, Carboplatin, Cisplatin)

        Not yet recruiting
        • Endometrial Cancer
        • Endometrial Adenocarcinoma
        • (no location specified)
        Oct 7, 2023

        Advanced Malignant Tumor, Delirium, Locally Advanced Malignant Tumor Trial in Houston (Chlorpromazine, Haloperidol,

        Active, not recruiting
        Has Results
        • Advanced Malignant Neoplasm
        • +4 more
        • Houston, Texas
          M D Anderson Cancer Center
        Oct 20, 2022

        Recurrent Lung Cancer, Lung Cancer Trial (Radiation: Diffusing Alpha Radiation Emitters Therapy (DaRT))

        Not yet recruiting
        • Recurrent Lung Cancer
        • Lung Cancer
        • Radiation: Diffusing Alpha Radiation Emitters Therapy (DaRT)
        • (no location specified)
        Nov 21, 2022

        Tislelizumab Combing Chemoradiotherapy in Recurrent Cervical

        Recruiting
        • Cervical Cancer
        • +2 more
        • Treatment Group
        • Shanghai, Shanghai, China
          Fudan University Shanghai Cancer Center
        May 9, 2023